Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

ClinicalTrials.gov ID: NCT03253094

Public ClinicalTrials.gov record NCT03253094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, double-dummy, active-controlled, dose-finding study to compare the efficacy, safety and tolerability of oral SCY-078 versus oral fluconazole in adult female subjects 18 years and older with moderate to severe Acute Vulvovaginal Candidiasis (AVVC). Approximately 180 eligible subjects (30 subjects per treatment group) will be enrolled and randomized into the study.

Study identification

NCT ID
NCT03253094
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Scynexis, Inc.
Industry
Enrollment
186 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2017 (Actual)
Primary completion
May 4, 2018 (Actual)
Completion
May 4, 2018 (Actual)
Last update posted
Aug 12, 2021

2017 – 2018

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
UAB Personal Health Clinic Birmingham Alabama 35294 —
Precision Trials AZ, LLC Phoenix Arizona 85032 —
Women's Health Care Research Corp. San Diego California 92111 —
Gulf Coast Research Group, LLC Brandon Florida 33510 —
Altus Research, Inc. Lake Worth Florida 33461 —
OB-GYN Associates of Mid-Florida P.A. Leesburg Florida 34748 —
New Age Medical Research Corp. Miami Florida 33186 —
Visionary Investigators Network South Miami Florida 33160 —
Atlanta North Gynecology, P.C. Roswell Georgia 30075 —
Cypress Medical Research Center, LLC Wichita Kansas 67226 —
Clinical Trials Management, LLC Covington Louisiana 70433 —
Clinical Trials Management, LLC Metairie Louisiana 70006 —
Women Under Study, LLC New Orleans Louisiana 70125 —
Tolan Park Medical Building Detroit Michigan 48201 —
Consultants in Women's Healthcare, Inc. St Louis Missouri 63131 —
Lawrence OB/GYN Clinical Research, LLC Lawrenceville New Jersey 08648 —
Women's Health Research Center Plainsboro New Jersey 08536 —
Unified Women's Clinical Research - Central Carolina Greensboro North Carolina 27408 —
Wake Research Associates, LLC Raleigh North Carolina 27612 —
Drexel University Philadelphia Pennsylvania 19102 —
Medical Research South, LLC Charleston South Carolina 29407 —
WR-Medical Research Center of Memphis, LLC Memphis Tennessee 38120 —
Tmc Life Research, Inc. Houston Texas 77054 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Seattle Women's Health, Research, Gynecology Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03253094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 12, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03253094 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →